Welfeed Remedies Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 30-12-2024
- Paid Up Capital ₹ 5.00 M
as on 30-12-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 30-12-2024
- Revenue 46.98%
(FY 2022)
- Profit 21.61%
(FY 2022)
- Ebitda 166.12%
(FY 2022)
- Net Worth 2.48%
(FY 2022)
- Total Assets 9.01%
(FY 2022)
About Welfeed Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹2.00 M.
Milanbhai Vagadiya, Ronak Vagadiya, and Khushal Vagadiya serve as directors at the Company.
- CIN/LLPIN
U24230GJ2012PTC072195
- Company No.
072195
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Welfeed Remedies Private Limited offer?
Welfeed Remedies Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Laxatives, Common Disease Medicines, Antihistamines, Digestive Drugs, Respiratory System Drugs, Asthma Inhaler, Antiemetic, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines.
Who are the key members and board of directors at Welfeed Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milanbhai Vagadiya  | Director | 04-Oct-2012 | Current |
| Ronak Vagadiya | Director | 04-Oct-2012 | Current |
| Khushal Vagadiya | Director | 04-Oct-2012 | Current |
Financial Performance of Welfeed Remedies.
Welfeed Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 46.98% increase. The company also saw a substantial improvement in profitability, with a 21.61% increase in profit. The company's net worth moved up by a moderate rise of 2.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Welfeed Remedies?
In 2021, Welfeed Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Aug 2019 | ₹2.00 M | Open |
How Many Employees Work at Welfeed Remedies?
Unlock and access historical data on people associated with Welfeed Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Welfeed Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Welfeed Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
